CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 7 incoming connections
- ScaleMarket cap is $59.91B, higher than 95% of all stocks globally
- PositionReturn on equity is 107.1%, higher than 95% of its Medical Distribution peers (median 7.6%)
- Interpretations7 currently firing — 7
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.78%Below 5Y avg (1.01%)
Annual Rate
USD 2.40Paid quarterly
Payout Ratio
17.6%Sustainable
Consecutive Growth
3 yr
Paying Dividends
25 yr
Last Ex-Dividend
May 15, 2026
Last Payment
Jun 1, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
59.91BUSDvs all stocks (USD)
Trailing P/E
23.60xvs Medical Distribution peers
Revenue (TTM)
328.68BUSDvs all stocks (USD)
Profit Margin
0.78%vs Medical Distribution peers
Beta
0.5810xvs all stocks
52-Week Change
5.20%vs all stocks
Forward Annual Dividend Yield
0.78%vs all stocks
Market Capitalization
59.91BUSDvs all stocks (USD)
Enterprise Value
70.80BUSDvs all stocks (USD)
Trailing P/E
23.60xvs Medical Distribution peers
Forward P/E
15.54xvs Medical Distribution peers
PEG Ratio
0.1842xvs Medical Distribution peers
Price to Sales (TTM)
0.1823xvs Medical Distribution peers
Price to Book (MRQ)
17.64xvs Medical Distribution peers
Enterprise to Revenue
0.2150xvs Medical Distribution peers
Enterprise to EBITDA
13.36xvs Medical Distribution peers
Gross Margin
4.58%vs Medical Distribution peers
Profit Margin
0.78%vs Medical Distribution peers
Operating Margin
1.72%vs Medical Distribution peers
Return on Assets (TTM)
3.49%vs Medical Distribution peers
Return on Equity (TTM)
107.13%vs Medical Distribution peers
Revenue (TTM)
328.68BUSDvs all stocks (USD)
Revenue per Share (TTM)
1.69KUSDUpdated Jul 18, 2026Quarterly Revenue Growth
3.80%vs Medical Distribution peers
Gross Profit (TTM)
12.48BUSDvs all stocks (USD)
EBITDA (TTM)
6.55BUSDvs all stocks (USD)
Net Income (TTM)
2.55BUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
128.60%vs Medical Distribution peers
Operating Cash Flow (TTM)
2.28BUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-318.25MUSDvs all stocks (USD)
Forward Annual Dividend Rate
2.40USDUpdated Jul 18, 2026Forward Annual Dividend Yield
0.78%vs all stocks
Trailing Annual Dividend Rate
2.35USDUpdated Jul 18, 2026Trailing Annual Dividend Yield
0.76%vs all stocks
5-Year Average Dividend Yield
1.01%vs all stocks
Payout Ratio
17.62%vs Medical Distribution peers
Minority Interest (Equity)
239.07MUSDFY2025 · Sep 30, 2025Revenue
321.33BUSDFY2025 · Sep 30, 2025Cost of Goods Sold
309.85BUSDFY2025 · Sep 30, 2025Gross Profit
11.48BUSDFY2025 · Sep 30, 2025Operating Income
3.93BUSDvs all stocks (USD)
Pre-tax Income
2.26BUSDFY2025 · Sep 30, 2025Income Tax Expense
690.52MUSDFY2025 · Sep 30, 2025Net Income
1.57BUSDFY2025 · Sep 30, 2025EBIT
2.68BUSDFY2025 · Sep 30, 2025EBITDA (Income Statement)
5.05BUSDFY2025 · Sep 30, 2025Selling, General & Administrative
6.49BUSDFY2025 · Sep 30, 2025Non-operating Interest Income
128.21MUSDFY2025 · Sep 30, 2025Non-operating Interest Expense
419.75MUSDFY2025 · Sep 30, 2025EPS (Basic)
8.02USDFY2025 · Sep 30, 2025EPS (Diluted)
7.96USDFY2025 · Sep 30, 2025Basic Shares Outstanding
193.82MSharesFY2025 · Sep 30, 2025Diluted Shares Outstanding
193.82MSharesFY2025 · Sep 30, 2025Net Income from Continuing Operations
1.57BUSDFY2025 · Sep 30, 2025Minority Interests (P&L)
-13.64MUSDFY2025 · Sep 30, 2025Operating Cash Flow
2.91BUSDFY2025 · Sep 30, 2025Cash & Cash Equivalents (End of Period)
4.39BUSDFY2025 · Sep 30, 2025Starting Profit (CF Statement)
1.57BUSDFY2025 · Sep 30, 2025Depreciation & Amortization
1.07BUSDFY2025 · Sep 30, 2025Deferred Taxes (CF)
59.86MUSDFY2025 · Sep 30, 2025Stock-based Compensation
147.96MUSDFY2025 · Sep 30, 2025Other Non-cash Items
-35.35MUSDFY2025 · Sep 30, 2025Change in Accounts Receivable (CF)
-1.92BUSDFY2025 · Sep 30, 2025Change in Accounts Payable (CF)
3.69BUSDFY2025 · Sep 30, 2025Change in Other Assets/Liabilities
-1.67BUSDFY2025 · Sep 30, 2025Net Acquisitions
-4.29BUSDFY2025 · Sep 30, 2025Other Investing Activity
-17.44MUSDFY2025 · Sep 30, 2025Net Investing Cash Flow
-4.31BUSDFY2025 · Sep 30, 2025Long-term Debt Issuance
4.51BUSDFY2025 · Sep 30, 2025Long-term Debt Payments
-133.45BUSDFY2025 · Sep 30, 2025Net Short-term Debt Issuance
-32.20MUSDFY2025 · Sep 30, 2025Common Stock Repurchase
-435.47MUSDFY2025 · Sep 30, 2025Common Dividends Paid
-437.08MUSDFY2025 · Sep 30, 2025Other Financing Charges
-103.14MUSDFY2025 · Sep 30, 2025Net Financing Cash Flow
-129.95BUSDFY2025 · Sep 30, 2025Shares Outstanding
194.56MSharesUpdated Jul 18, 2026Float Shares
184.00MSharesUpdated Jul 18, 2026Shares Short
5.50MSharesUpdated Jul 18, 2026Short Ratio
3.51daysvs all stocks
Short % of Shares Outstanding
3.21%vs all stocks
% Held by Insiders
4.23%vs all stocks
% Held by Institutions
98.91%vs all stocks
Total Cash (MRQ)
2.18BUSDvs all stocks (USD)
Total Cash per Share (MRQ)
11.19USDUpdated Jul 18, 2026Total Debt (MRQ)
15.09BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
4.21xvs Medical Distribution peers
Current Ratio (MRQ)
0.9470xvs Medical Distribution peers
Book Value per Share (MRQ)
17.46USDUpdated Jul 18, 2026Total Assets
76.59BUSDvs all stocks (USD)
Total Current Assets
52.24BUSDFY2025 · Sep 30, 2025Total Liabilities
74.84BUSDFY2025 · Sep 30, 2025Total Non-current Assets
24.35BUSDFY2025 · Sep 30, 2025Total Non-current Liabilities
17.02BUSDFY2025 · Sep 30, 2025Total Current Liabilities
57.82BUSDFY2025 · Sep 30, 2025Cash & Cash Equivalents
4.36BUSDFY2025 · Sep 30, 2025Accounts Receivable
25.23BUSDFY2025 · Sep 30, 2025Inventory
20.49BUSDFY2025 · Sep 30, 2025Accounts Payable
54.72BUSDFY2025 · Sep 30, 2025Short-term Debt
117.78MUSDFY2025 · Sep 30, 2025Long-term Debt
7.54BUSDFY2025 · Sep 30, 2025Other Non-current Liabilities
3.64BUSDFY2025 · Sep 30, 2025Common Stock (Book)
2.97MUSDFY2025 · Sep 30, 2025Retained Earnings
6.53BUSDFY2025 · Sep 30, 2025Total Shareholders' Equity
1.75BUSDvs all stocks (USD)
Treasury Stock
10.33BUSDFY2025 · Sep 30, 202552-Week Low
244.82USDUpdated Jul 18, 202652-Week High
377.54USDUpdated Jul 18, 202652-Week Change
5.20%vs all stocks
Beta
0.5810xvs all stocks
50-Day MA
278.27USDUpdated Jul 18, 2026200-Day MA
324.62USDUpdated Jul 18, 2026Avg 10-Day Volume
1.37MSharesUpdated Jul 18, 2026Avg 30-Day Volume
1.49MSharesUpdated Jul 18, 2026Diluted EPS (TTM)
13.05USDUpdated Jul 18, 2026Other Income / Expense
-1.38BUSDFY2025 · Sep 30, 20257 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Diagnostic
Elevated ROE With High Debt-to-Equity and Equity Multiplier
Return on equity reads high on a balance sheet carrying a lot of debt against that equity.
Reads
High ROE Relative To Gross Margin
Its return on equity is high for the gross margin it earns, with revenue up three years and profit in all five.
Reads
Industry-Benchmarked Return on Capital Elevated
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
Low Fixed-Asset Share With Elevated Turnover
It owns few buildings and machines, yet gets more sales and profit from its assets than its industry does.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
Where is this company structurally exposed?
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Reads
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Return on equity is 107.1%, higher than 95% of its Medical Distribution peers (median 7.6%)Significant
Return on equity: 1.07Industry median: 0.08Industry P95: 0.23Peers compared: 32.00
Debt-to-equity is 4.21×, higher than 95% of its Medical Distribution peers (median 0.4×)Significant
Debt-to-equity: 4.21Industry median: 0.40Industry P95: 1.81Peers compared: 32.00
Price-to-book is 17.64×, higher than 95% of its Medical Distribution peers (median 1.03×)Significant
Price-to-book: 17.64Industry median: 1.03Industry P95: 5.47Peers compared: 32.00
Financial Health
Altman Z-Score 4.82: safe zoneNotable
Altman Z-Score: 4.82
High earnings qualityNotable
Earnings Quality Score: 1.59
Supply Chain
Midstream position: 6 outgoing, 7 incoming connectionsNotable
Outgoing: 6.00Incoming: 7.00
High connectivity hub: 13 industry connectionsNotable
Total Connections: 13.00
Scale
Market cap is $59.91B, higher than 95% of all stocks globallySignificant
Market cap (USD): 59,905,348,428Global P95: 25,614,208,870.135
Revenue is $328.68B, higher than 95% of all stocks globallySignificant
Revenue (USD): 328,680,013,824Global P95: 14,667,937,174.886
Levered free cash flow is -$318.25M, lower than 95% of all stocks globallySignificant
Levered free cash flow (USD): -318,246,112Global P5: -219,013,500
Companies that share the same coordination system — how they create, deliver, or capture value.
Targa Resources Corp.
Tier 1FlowThroughput-Bound ConversionProductionRisk
DSV A/S
Tier 1FlowThroughput-Bound ConversionInterfaceProduction
Cheniere Energy Inc.
Tier 1FlowThroughput-Bound ConversionProductionRisk
W.W. Grainger, Inc.
Tier 1FlowThroughput-Bound ConversionInterfaceProduction
Cardinal Health Inc.
Tier 1FlowThroughput-Bound ConversionProductionRisk
Fastenal Company
Tier 1FlowThroughput-Bound ConversionInterfaceProduction
América Móvil, S.A.B. de C.V.
Tier 1FlowThroughput-Bound ConversionRuleRisk
DHL Group AG
Tier 1FlowThroughput-Bound ConversionRiskInterface
O'Reilly Automotive Inc.
Tier 1FlowThroughput-Bound ConversionInterfaceProduction
AutoZone Inc.
Tier 1FlowThroughput-Bound ConversionInterfaceProduction
Companies that share active interpretations — structural patterns currently present in both stocks.
Henan Yuguang Gold & Lead Co., Ltd.
6 interpretationsElevated Leverage on Three DenominatorsElevated ROE With High Debt-to-Equity and Equity MultiplierMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked Return on Capital ElevatedHigh ROE Relative To Gross MarginLow Fixed-Asset Share With Elevated Turnover
Atmus Filtration Technologies Inc.
6 interpretationsElevated Leverage on Three DenominatorsElevated ROE With High Debt-to-Equity and Equity MultiplierMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked Return on Capital ElevatedHigh ROE Relative To Gross MarginLow Fixed-Asset Share With Elevated Turnover
Aveanna Healthcare Holdings Inc.
5 interpretationsElevated Leverage on Three DenominatorsReceivables Heavy and GrowingElevated ROE With High Debt-to-Equity and Equity MultiplierIndustry-Benchmarked Return on Capital ElevatedLow Fixed-Asset Share With Elevated Turnover